1.Clinical analysis of 68 cases of bilateral thyroid carcinoma
Lijun REN ; Yanfang YANG ; Qinghui SUN ; Feng GUO ; Chenglei ZHANG
Journal of Endocrine Surgery 2009;3(5):325-327
Objective To investigate the diagnosis and treatment of bilateral thyroid carcinoma(BTC).Methods Clinical data of 68 cases with BTC from July 2001 to July 2008 were analyzed retrospectively.Results All patients underwent surgical treatment.22 cases received total thyroidectomy and bilateral functional neck dissection,30 cases received total thyroidectomy and unilateral functional neck dissection,14 cases received total thyroidectomy and lymph node dissection of Ⅵ area,2 cases received palliative resection.12 cases received proper radioactive 131I therapy after operation.Postoperative complications occured in 16 cases,including 5 cases with transient recurrent nerve paralysis,1 case with permanent injury of recurrent laryngeal nerves received trachea incision,1 case with tracheomalacia and asphyxia,6 cases with convulsion caused by hypocalcemia,1 case with permanent hypoparathyroidism,2 cases with chylous fistula(one was cured by saturing and ligaturing and the other by conservative treatment).Low echo solid or cystic solid nodules in thyroid were found by preoperative ultrasonic scan in all cases,in which 38(55.88%)cases were associated with gravel calcified lesion in thyroid nodules.The diagnosis was comfirmed by needle aspiration biopsy(NAB)in 42 cases preoperatively and 64 cases(94.12%)by frozen section intraoperatively.63(92.64%)cases were followed up postoperatively for a period from 6 months to 5 years,all 5 cases with recurrence and/or metastasis had tumor-free survival after reoperation except for 1 case with undifferentiated cancer died on the 6th month after operation.Conclusions Total thyroidectomy and lymph node dissection is essential to the treatment of BTC.Gravel calcified lesion revealed by preoperative high frequency ultrasonagraphy is an important characteristic for preoperative diagnosis of thyroid cancer.
2.Mechanism of action of protein phosphatase 2A in the promotion and inhibition of hepatocellular carcinoma
Chenglei YANG ; Shen HUANG ; Zhiming ZHANG
Journal of Clinical Hepatology 2019;35(5):1123-1128
Protein phosphatase 2A (PP2A) is a major serine/threonine phosphatase involved in many signaling pathways associated with cell growth and proliferation, and it also regulates many cellular processes. With an in-depth exploration of PP2A in the process of cell activity, especially malignant tumors, the association between PP2A and hepatocellular carcinoma (HCC) has attracted more and more attention in recent years; however, there is still a controversy over whether PP2A can promote or inhibit HCC. This article reviews the research advances in the mechanism of action of PP2A as a tumor factor in the regulation of HCC and target therapy.
3.Research advances in targeted therapy for hepatocellular carcinoma
Shen HUANG ; Chenglei YANG ; Zhiming ZHANG
Journal of Clinical Hepatology 2019;35(11):2573-2577
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Due to the insidious onset, poor prognosis, and lack of specificity of HCC, most patients have reached the advanced stage at the time of diagnosis. Conventional treatment methods, such as surgical resection, liver transplantation, radiotherapy, and chemotherapy, have limited therapeutic effects and fail to bring significant benefits to patients. With the improvement of science and technology and medical level in recent years, targeted therapy drugs have gradually entered people’s vision due to the breakthroughs in the treatment of HCC and thus bring new hope to patients with advanced HCC. Targeted drugs have attracted wide attention due to good molecular selectivity, targeted killing of tumor cells, and protection of normal tissue. This article reviews the research advances in targeted therapy for HCC.
4.Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings
Chenglei LIU ; Yan XI ; Mei LI ; Qiong JIAO ; Huizhen ZHANG ; Qingcheng YANG ; Weiwu YAO
Korean Journal of Radiology 2019;20(5):801-811
OBJECTIVE: To determine whether diffusion kurtosis imaging (DKI) is effective in monitoring tumor response to neoadjuvant chemotherapy in patients with osteosarcoma. MATERIALS AND METHODS: Twenty-nine osteosarcoma patients (20 men and 9 women; mean age, 17.6 ± 7.8 years) who had undergone magnetic resonance imaging (MRI) and DKI before and after neoadjuvant chemotherapy were included. Tumor volume, apparent diffusion coefficient (ADC), mean diffusivity (MD), mean kurtosis (MK), and change ratio (ΔX) between pre- and post-treatment were calculated. Based on histologic response, the patients were divided into those with good response (≥ 90% necrosis, n = 12) and those with poor response (< 90% necrosis, n = 17). Several MRI parameters between the groups were compared using Student's t test. The correlation between image indexes and tumor necrosis was determined using Pearson's correlation, and diagnostic performance was compared using receiver operating characteristic curves. RESULTS: In good responders, MDpost, ADCpost, and MKpost values were significantly higher than in poor responders (p < 0.001, p < 0.001, and p = 0.042, respectively). The ΔMD and ΔADC were also significantly higher in good responders than in poor responders (p < 0.001 and p = 0.01, respectively). However, no significant difference was observed in ΔMK (p = 0.092). MDpost and ΔMD showed high correlations with tumor necrosis rate (r = 0.669 and r = 0.622, respectively), and MDpost had higher diagnostic performance than ADCpost (p = 0.037) and MKpost (p = 0.011). Similarly, ΔMD also showed higher diagnostic performance than ΔADC (p = 0.033) and ΔMK (p = 0.037). CONCLUSION: MD is a promising biomarker for monitoring tumor response to preoperative chemotherapy in patients with osteosarcoma.
Bone Neoplasms
;
Diffusion
;
Drug Therapy
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Necrosis
;
Osteosarcoma
;
ROC Curve
;
Tumor Burden
5.Exploring the “Inflammation-Cancer” Transformation of Ulcerative Colitis and Its Prevention and Treatment Based on the Method of Regulating Qi and Resolving Toxins
Bingwei YANG ; Xue CHEN ; Chenglei WANG ; Weidong LI ; Baojin HUA
Journal of Traditional Chinese Medicine 2024;65(5):469-473
Based on the method of regulating qi and resolving toxins, this paper discussed the core pathogenesis of “inflammation-cancer” transformation of ulcerative colitis. It is believed that the disorder of qi movement, endogenous pathogenic factors of “heat, stasis and dampness” are cemented in the large intestine, and the pathogenic factors are too excessive to be solved, which will become toxic after a long time and lead to cancerous changes. Clinical prevention and treatment applies the method of regulating qi and resolving toxins, and the method of regulating qi was proposed as clearing internal qi, regulating blood qi and strengthening spleen qi, so as to clear heat, dissipate blood stasis and dissolve dampness; different methods of regulating qi and resolving toxins were flexibly combined according to the pathogenic characteristics of different stages of toxicity, in order to interrupt the process of “inflammation-cancer” transformation of ulcerative colitis.
6.Research progress on the mechanism of saponin compounds intervening in colorectal cancer by regulating gut microbiota
Haoyu ZHAI ; Xue CHEN ; Bingwei YANG ; Chenglei WANG ; Weidong LI
China Pharmacy 2024;35(19):2426-2431
Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. Specific gut microbiota can identify high-risk populations for colorectal cancer and may slow disease progression by regulating apoptosis, producing intestinal metabolites, and enhancing chemotherapy efficacy (reducing side effects and improving chemotherapy resistance). Saponins represented by ginsenoside K are found widely in traditional medicines such as Panax ginseng and Panax notoginseng. After metabolized by gut microbiota, they play a role in preventing and treating colorectal cancer by modulating chronic inflammation, adjusting the composition of gut microbiota, generating microbial metabolites, and participating in immune regulation.
7.Research advances in the formation mechanism of primary intrahepatic stones caused by biliary flora
Jiangping REN ; Jinfei QIU ; Yang ZOU ; Xiaobei CAI ; Chenglei XU ; Jiang LI
Journal of Clinical Hepatology 2022;38(2):477-482
Primary intrahepatic stones (PIS) is a refractory disease with a high incidence rate in southwest China, and some patients still require surgery again or even more times after initial treatment. Many studies in recent years have shown that some specific flora can colonize in the intrahepatic bile duct, leading to chronic infection and inflammation of the biliary system, and these specific types of flora, called "stone-causing flora", can produce metabolites such as β-glucuronidase and play an important role in the formation of pigmented stones. This article analyzes the role of stone-causing flora in the pathogenesis of PIS, so as to provide more treatment options for PIS patients.
8.Roles of Tet2 in meiosis, fertility and reproductive aging.
Huasong WANG ; Linlin LIU ; Mo GOU ; Guian HUANG ; Chenglei TIAN ; Jiao YANG ; Haiying WANG ; Qin XU ; Guo Liang XU ; Lin LIU
Protein & Cell 2021;12(7):578-585